Back
Bio-Rad Laboratories 10K Form
Buy
62
BIO.B
Bio-Rad Laboratories
Last Price:
332.00
Seasonality Move:
2.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIO.B News And Ratings
See the #1 stock for the next 7 days that we like better than BIO.B
BIO.B Financial Statistics
Sales & Book Value
| Annual Sales: | $2.67B |
|---|---|
| Cash Flow: | $99.97M |
| Price / Cash Flow: | 42.54 |
| Annual Sales: | $267.46 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | -27.33000 |
|---|---|
| Net Income (TTM): | $-778.69M |
| Gross Margin: | $1.43B |
| Return on Equity: | -9.62% |
| Return on Assets: | -6.82% |
Bio-Rad Laboratories Earnings Forecast
Key Bio-Rad Laboratories Financial Ratios
- The Gross Profit Margin over the past 40 years for BIO.B is 53.42%.
- The Selling, General & Administrative Expenses for BIO.B have been equal to 31.51% of Gross Profit Margin.
- The Research & Development expenses have been 9.26% of Revenue.
- The Interest Expense is -7.76% of Operating Income.
- The Net Earning history of BIO.B is -23.86% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Bio-Rad Laboratories Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BIO.B |
| Website: | bio-rad.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 6.14 |
| Quick Ratio: | 4.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BIO.B Technical Analysis vs Fundamental Analysis
Buy
62
Bio-Rad Laboratories (BIO.B)
is a Buy
Is Bio-Rad Laboratories a Buy or a Sell?
-
Bio-Rad Laboratories stock is rated a Buy
The current Bio-Rad Laboratories [BIO.B] share price is $334.85. The Score for BIO.B is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.